Pharmaceutical Industry Residency Program

Pharmaceutical Industry Residency Program (PIRP)

The Pharmaceutical Industry Residency Program, formerly named the Industrial Pharmacy Residency Program, is administered by the Leslie Dan Faculty of Pharmacy, University of Toronto, in cooperation with participating Pharmaceutical Companies as listed below. These one or two year specialty residencies develop critical knowledge and skills and provide experience within the stated functional area. This is a national educational residency program for graduates from a recognized Pharmacy degree program; it is not an application for a position with a pharmaceutical company.

New this year

Over the last few years, many residents and company supervisors have communicated a desire to formally certify the program and we are excited to announce that we have successfully achieved program certification through the Leslie Dan Faculty of Pharmacy, University of Toronto. Current residents are eligible for the certificate provided they complete the requirements outlined in the terms of reference.

The Leslie Dan Faculty of Pharmacy will continue to support PIRP’s ability to provide high, quality, experiential learning through:

Skills and educational webinars and exposure to pharmaceutical industry experts
Resume and interview skills workshops
Opportunity to network with PIRP residents and pharmaceutical industry professionals
Participation in a new mentoring program with a PIRP graduate
Collaboration with and guidance from University of Toronto faculty liaisons
Coordination to address issues and ensure program requirements are met

PIRP Fees

To help fund this program, starting in the 2024-25 cycle the program fees are as follows:

Pharmaceutical company fees based on the number of residency positions offered:

Positions #1 to #3

$5,000 per position then

Positions #4 to #10

$3,000 per position then

All positions >10

$2,000 per position 

Applicant and resident non-refundable fees:

$250 at application (Sept 2023)
$2250 once successfully matched with a company (March 2024)
$2500 payable three months after residency employment starts (Q3-Q4 2024)

Applications Process - Open Friday, September 1st, 2023 at 9:00am ET

Applications are now invited for Residencies occurring from September 2024 to August 2025. Please click here if you are a current U of T student where you will login with your UTORID to access the application form and process.

If you are not currently a U of T student, please click here for a login. (This may take 3-5 business days so please do as soon as possible). Once your account has been activated, you can login here.

*Please note that you will not receive an email confirmation once the account has been created and will have to manually check by logging in.

In the interim, you may prepare to upload the following as part of the application:

Applicant Contact Information
University Transcripts from Pharmacy program (in PDF format; unofficial copy accepted – verification may be required)
Resume or CV
Reference form (listing contact information of two referees) (click here)

Note: Applications will be accepted until Monday, October 2nd, 2023 at 5:00pm ET . Approved applicants will then have until Friday, October 20th at 5:00pm ET to finalize their selection of positions. We recommend initiating your application through the CLN “here” link above as soon as possible.

Residency matching results from individual companies will be communicated to successful applicants starting on February 23, 2024 and no longer align with the Hospital Residency Program timelines.

The Product Development Regulatory and Annual Product Quality Review residencies with Roche, and the residencies with AstraZeneca will be 24 months in length. Please review the updated Terms of Reference document for more information.

2024-2025 Participating Companies